Inflammatory Bowel Disease
Report summarizes inflammatory bowel disease in children study findings from Institute of Child Health, Department of Pediatrics
Published in Gastroenterology Week, March 19th, 2007
New investigation results, "Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results," are detailed in a study published in Alimentary Pharmacology & Therapeutics. "Anti-tumour necrosis factor-alpha antibodies are useful for the treatment of refractory Crohn's disease and ulcerative colitis. Thalidomide is another agent with tumor necrosis factor-alpha suppressive properties," researchers in Trieste, Italy report.
"To investigate the long-term efficacy and safety of thalidomide in a group of children and young adults with refractory inflammatory bowel disease. Twenty-eight patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Bariatrics
Weight Loss Surgery Rate Increases Among Teens, But Use of Procedure Still Uncommon in Adolescents - Breast Cancer
Ovarian cancer may mimic fallopian tube formation - Colon Cancer
Aspirin Or NSAIDs Won't Prevent Colorectal Cancer - Colon Cancer
Want a Healthy Colon? Eat a Rainbow - Diarrhea
Mothers in African study undereducated on diarrhea - Hepatocellular Cancer
Outcomes for patients with hepatitis B who need liver transplants - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
